abstracts

Sarcopenia is Associated with Social Determinants of Health in Patients with Inflammatory Bowel Disease

BACKGROUND: Sarcopenia is defined as the loss of skeletal muscle mass and is a modifiable condition that affects between 27 to 61% of patients with inflammatory bowel disease (IBD). Socia...

Ayushi Jain ;

Kavita Ramnath ;

Laurie Rosales ;

Beth Kulow ;

Jacob Skeans ;

Madalina Butnariu ;

Adeeti Chiplunker ;

Anita Afzali ;

12/15/2022

P065 A One-Time Education for Gastroenterologists Regarding Osteoporosis Screening for IBD Patients Improves Provider Knowledge But Not Screening Rates

BACKGROUND: Inflammatory Bowel Disease (IBD) is a chronic gastrointestinal inflammatory condition and has been increasing in prevalence in the United States, with a 30-40% inc...

Subin Chirayath ;

Dhruv Patel ;

Dhruvanshu Patel ;

Parampreet Kaur ;

Yecheskel Schneider ;

12/15/2021

P076 The Role of Dual Biologic Therapy in Inflammatory Bowel Disease

BACKGROUND: As the prevalence of complex inflammatory bowel disease and extraintestinal manifestations continue to rise, more patients are requiring complex treatment regimens...

Erin Forster , MD, MPH;

Molly Stone ;

Margaret Morrison ;

12/15/2021

P066 Real-World Experience of Ustekinumab in Crohn's Disease Patients With Prior Anti-TNF Therapy at a Tertiary Care Hospital

BACKGROUND: Ustekinumab (UST) is a monoclonal antibody against the p40 subunit of IL-12/23. It is approved for the treatment of moderate to severe Crohn's disease (CD) and Ulc...

Kartikeya Tripathi ;

Kevin Groudan ;

Jean Chalhoub ;

Arushika Yedla ;

Rohit Singhania ;

12/15/2021

P077 Incidence of Colonic Strictures — A Systematic Review and Meta-analysis

BACKGROUND: Intestinal strictures are a complication of the inflammatory bowel diseases (IBD, including ulcerative colitis (UC) and Crohn’s disease (CD)) that can lead to bowe...

Abhishek Bhurwal , MD;

Roohi Patel ;

Hemant Mutneja ;

Darren Seril ;

John H. Stroger Jr.;

12/15/2021

P067 Immune Checkpoint Inhibitor Colitis in a Community-Based Hospital System

BACKGROUND: Immune checkpoint inhibitors (ICIs) have significantly changed the oncologic treatment landscape for a wide array of cancers over the past few decades. While these...

Aaron Rampersad ;

Gary Abrams ;

Christina Bauer ;

12/15/2021

P068 Racial and Socioeconomic Disparities in Acute Care Utilization in a National Cohort of Veterans With IBD

BACKGROUND: Hospitalizations for Black patients with inflammatory bowel disease (IBD) have increased in recent decades though our understanding of disease behavior in Black pa...

Alexander Booth ;

Everette Keller ;

Erin Forster , MD, MPH;

Robert Axon ;

Gayenell Magwood ;

Thomas Curran ;

12/15/2021

P069 The Unrelenting Ulcer

CASE: Inflammatory Bowel Disease (IBD) is becoming more common in an increasingly diverse population. Exposure history is important, especially when prescribing immunosuppress...

Emmanuelle Williams ;

Michelle Rosario ;

12/15/2021

P070 Next Generation Wearable Technology for IBD Patients: A Feasibility Study

BACKGROUND: Inflammatory Bowel Disease (IBD) prevalence is rising. Quality of life (QOL) in chronic illness is affected by various physical and psychosocial factors. Recent st...

Kara DiJoseph ;

Alex Hajduczok ;

Andrew Tinsley ;

Michelle Rosario ;

12/15/2021

P071 COVID-19 Ethics and Gastroenterology

BACKGROUND: Ethical principles in the field of medicine have become increasingly relevant during the COVID-19 pandemic, during which practitioners are required to provide care...

Priya Dave ;

12/15/2021

abstracts

Follow Us on Twitter!

Specialties

Events

Year Round Education

HMP Global Products